Early Detection of Patients with Eating Disorders in General Practice
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age16+
SponsorDonini Lorenzo M
About this trial
The goal of this observational study is to assess the efficacy of the Eating Disorder Proxy Screening Tool for General Practitioner (ED-PSTGP) as a tool for the early detection of eating disorders (EDs) in General Practice (GP). The ED-PSTGP is a hetero-evaluative questionnaire that investigates the presence of suspected eating disorder symptoms among the family members of the person completing the questionnaire. The study will involve adult patients over 18 years old enrolled in a general practice and their family members aged 16 years or older.
The main questions it aims to answer are:
* Can the ED-PSTGP questionnaire effectively identify patients with potential eating disorders through responses from a family member? * How effective is the ED-PSTGP questionnaire in general practice as an early detection tool for eating disorders?
Participants will:
* Be asked by their General Practitioner (GP) to complete the ED-PSTGP questionnaire. * If a positive result is found, invite the potentially affected family member to complete additional screening questionnaires online.
The potentially affected family member will be offered a teleconsultation with specialists and encouraged to contact the nearest reference center for ED treatment to further investigate potential eating disorders.
Eligibility criteria
Qualifiers
Age ≥ 18 years, for patients enrolled by a General Practitioner (GP) to complete the ED-PSTGP questionnaire.
Ability to provide informed consent for participation in the study.
Age ≥ 16 years, for family members of GP patients, identified as pontentially affected by an eating disorder.
Disqualifiers
Inability to provide informed consent
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
Sponsors and collaborators
Donini Lorenzo M
Lead sponsor
University of Roma La Sapienza
Sponsor institution
Source ClinicalTrials.gov